Workflow
Pineapple Energy (PEGY) - 2025 Q1 - Quarterly Report
2025-05-15 20:21
Financial Performance - Sales for the three months ended March 31, 2025, were $12.64 million, a decrease of 4.4% compared to $13.22 million for the same period in 2024[15]. - Gross profit for Q1 2025 was $4.43 million, down from $4.81 million in Q1 2024, reflecting a decrease of 7.2%[15]. - Operating loss for the three months ended March 31, 2025, was $2.17 million, slightly improved from a loss of $2.18 million in Q1 2024[15]. - Net loss attributable to common shareholders for Q1 2025 was $3.50 million, compared to a net loss of $10.12 million in Q1 2024, indicating a significant reduction in losses[15]. - Basic net loss per share for Q1 2025 was $106.71, compared to $38,414.84 for Q1 2024, reflecting the impact of reverse stock splits[15]. - Total revenues for SUNation were $9,544,554 in Q1 2025, down from $9,752,970 in Q1 2024, reflecting a decrease of 2.1%[74]. - For the three months ended March 31, 2025, SUNation reported residential contract revenues of $7,896,122, a decrease of 2.9% from $8,131,708 in the same period of 2024[74]. - Commercial contract revenues increased to $1,275,888 in Q1 2025 from $997,193 in Q1 2024, representing a growth of 28%[74]. - Net loss before income taxes for Q1 2025 was $(3,481,817), compared to a net income of $1,208,813 in Q1 2024, highlighting a significant decline in profitability[152]. - Selling, general and administrative expenses for Q1 2025 totaled $6,039,298, compared to $6,629,027 in Q1 2024, indicating a reduction in overhead costs[151]. Assets and Liabilities - Total assets decreased to $44.43 million as of March 31, 2025, from $45.71 million as of December 31, 2024, representing a decline of approximately 2.8%[10]. - Total current liabilities decreased to $20.27 million as of March 31, 2025, from $27.16 million as of December 31, 2024, a reduction of approximately 25.5%[10]. - The company reported cash and cash equivalents of $1.45 million as of March 31, 2025, up from $839,268 as of December 31, 2024, an increase of approximately 72.5%[10]. - Inventories decreased to $2.51 million as of March 31, 2025, from $2.71 million as of December 31, 2024, a decline of approximately 7.2%[10]. - The balance of accumulated deficit as of March 31, 2025, was $(46,395,478), an increase from $(25,850,588) as of March 31, 2024[18]. Capital and Financing Activities - The company raised $9,473,398 from the issuance of common stock and pre-funded warrants under a registered direct offering during the three months ended March 31, 2024[22]. - The company raised approximately $20.0 million in aggregate gross proceeds from a securities offering, with $5 million from the second tranche closing on April 7, 2025[168]. - The company issued 9,825 shares of common stock under a registered direct offering, netting $8,481,892[17]. - The At the Market Offering Agreement allows the Company to sell up to $10,000,000 in common stock, with 762 shares sold for gross proceeds of $362,269 during the three months ended March 31, 2025[136]. - The Company executed a reverse stock split at a 1-for-50 ratio on October 1, 2024, reducing outstanding shares from 67,260,696 to 1,344,841[33]. - A subsequent reverse stock split at a 1-for-200 ratio was approved on April 3, 2025, reducing outstanding shares from 672,799,910 to 3,406,614[39]. - The Company increased its authorized shares to 1,000,000,000 as part of the April 2025 reverse stock split approval[36]. Debt and Interest Obligations - The loan payable to Hercules Capital, Inc. was originally $7,500,000, with an interest rate of 10%, and was due on December 31, 2024, after amendments to the Term Loan Agreement[80][81]. - The Term Loan Agreement was amended on May 31, 2023, resulting in a remaining balance of $3,375,742, with a new maturity date of June 2, 2027, and an interest rate of 10%[82]. - The Company recorded a loss on extinguishment of debt of $455,308 upon full repayment of the Term Loan on March 3, 2025[85]. - The Company recorded interest and accretion expense of $33,312 for the three months ended March 31, 2025, compared to $0 for the same period in 2024[105]. - Interest paid increased to $1,077,033 from $416,504 in the previous year[22]. Strategic Initiatives - The company’s strategy focuses on acquiring and integrating leading local and regional solar, storage, and energy services companies nationwide[26]. - The company aims to expand its operations by acquiring and integrating leading local and regional solar, storage, and energy services companies nationwide[26]. - The company plans to raise capital through public or private equity offerings, debt financings, and/or strategic alliances[166]. Accounting and Compliance - The Company is currently evaluating the impact of new accounting standards issued by the FASB, including ASU 2023-06 and ASU 2023-09, which may affect its consolidated financial statements[69][71]. - The effective income tax rate from continuing operations was (0.4%) for the three months ended March 31, 2025, differing from the federal tax rate of 21% due to state income taxes[145]. - The Company’s segment structure now includes distinct reportable segments for SUNation and Hawaii Energy Connection (HEC) due to changes in economic forecasts[148]. Market and Operational Challenges - The company received a Nasdaq delisting notice on April 11, 2025, due to not maintaining a minimum closing bid price of $1.00 per share[172]. - The company has substantial doubt about its ability to continue as a going concern, requiring additional capital resources[165].
Toppoint Holdings Inc(TOPP) - 2025 Q1 - Quarterly Results
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2025 ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ ...
Edible Garden AG rporated(EDBL) - 2025 Q1 - Quarterly Report
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41371 EDIBLE GARDEN AG INCORPORATED (Exact name of registrant as specified in its charter) Delaware 85-0558704 (State or other jurisdiction of incorporation or organization) ( ...
Cardio Diagnostics (CDIO) - 2025 Q1 - Quarterly Report
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-41097 Cardio Diagnostics Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 87-0925574 (St ...
assetentities(ASST) - 2025 Q1 - Quarterly Report
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to _____________ Commission File Number: 001-41612 ASSET ENTITIES INC. (Exact name of registrant as specified in its charter) Nevada 88-1293236 ...
1847 LLC(EFSH) - 2025 Q1 - Quarterly Results
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 1847 Holdings LLC | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Delaware | 001-41368 | 38-3922937 | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | | 260 Madison Avenue, ...
Lakeside Holding Limited(LSH) - 2025 Q3 - Quarterly Results
2025-05-15 20:20
Exhibit 99.1 Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results ITASCA, IL, May 15, 2025 (GLOBE NEWSWIRE) -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 third quarter and nine months ended March 3 ...
Kintara Therapeutics(KTRA) - 2025 Q3 - Quarterly Results
2025-05-15 20:20
Financial Results and Updates - TuHURA Biosciences reported financial results for Q1 2025, with a focus on corporate updates[7]. - TuHURA's financial condition and operational results are detailed in the press release dated May 15, 2025[7]. - The company has not undertaken any obligation to update forward-looking statements unless required by securities laws[14]. Acquisition and Merger - The company is in the process of acquiring Kineta, Inc., with a registration statement filed on February 7, 2025[8]. - The merger with Kineta is expected to enhance TuHURA's capabilities in tumor microenvironment modulators[13]. - TuHURA is actively seeking additional capital to support the Kineta merger and its ongoing development programs[13]. - The company emphasizes the importance of reading the Joint Proxy Statement/Prospectus for detailed information regarding the merger[9]. Product Development - TuHURA's product candidate IFx-Hu2.0 is anticipated to enter Phase 3 trials, indicating progress in its development pipeline[13]. - The anticipated regulatory pathway and timing for TuHURA's development programs are outlined as part of their forward-looking statements[13]. Stock Information - TuHURA's stock is traded on The Nasdaq Capital Market under the symbol HURA[5].
TuHURA Biosciences, Inc.(HURA) - 2025 Q3 - Quarterly Results
2025-05-15 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Nevada 001-37823 99-0360497 (Commission File Number) (IRS Employer (State or Other Jurisdiction of Incorporation) Identification No.) FORM 8-K 10500 University Center Dr., Suite 110 Tampa, Florida 33612 (Address of Principal Executive Offices, including zip code) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Registrant's Telephone Number, Including Area Code: (813) 875-6600 Date of Report (Date of ...
Slam (SLAM) - 2025 Q1 - Quarterly Report
2025-05-15 20:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | SLAM CORP. | | --- | (Exact name of registrant as specified in its charter) | Cayman Islands | 001-40094 | 98-1211848 | | --- | --- | --- | | (State or other jurisd ...